PT Suparma Tbk (IDX:SPMA)

PT Suparma Tbk Statistics

Total Valuation

PT Suparma Tbk has a market cap or net worth of IDR 984.08 billion. The enterprise value is 1.53 trillion.

Market Cap	984.08B
Enterprise Value	1.53T

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

PT Suparma Tbk has 4.10 billion shares outstanding.

Current Share Class	4.10B
Shares Outstanding	4.10B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	81.58%
Owned by Institutions (%)	0.02%
Float	n/a

Valuation Ratios

The trailing PE ratio is 16.85.

PE Ratio	16.85
Forward PE	n/a
PS Ratio	0.36
PB Ratio	0.40
P/TBV Ratio	0.40
P/FCF Ratio	1.56
P/OCF Ratio	1.47
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.87, with an EV/FCF ratio of 2.43.

EV / Earnings	26.20
EV / Sales	0.55
EV / EBITDA	4.87
EV / EBIT	9.02
EV / FCF	2.43

Financial Position

The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.28.

Current Ratio	2.04
Quick Ratio	0.48
Debt / Equity	0.28
Debt / EBITDA	2.18
Debt / FCF	1.08
Interest Coverage	4.59

Financial Efficiency

Return on equity (ROE) is 2.41% and return on invested capital (ROIC) is 3.48%.

Return on Equity (ROE)	2.41%
Return on Assets (ROA)	3.08%
Return on Invested Capital (ROIC)	3.48%
Return on Capital Employed (ROCE)	6.00%
Revenue Per Employee	3.33B
Profits Per Employee	70.44M
Employee Count	808
Asset Turnover	0.80
Inventory Turnover	2.35

Taxes

In the past 12 months, PT Suparma Tbk has paid 18.30 billion in taxes.

Income Tax	18.30B
Effective Tax Rate	23.86%

Stock Price Statistics

The stock price has increased by +4.00% in the last 52 weeks. The beta is 0.70, so PT Suparma Tbk's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+4.00%
50-Day Moving Average	267.66
200-Day Moving Average	225.33
Relative Strength Index (RSI)	33.62
Average Volume (20 Days)	1,419,625

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PT Suparma Tbk had revenue of IDR 2.76 trillion and earned 58.40 billion in profits. Earnings per share was 14.24.

Revenue	2.76T
Gross Profit	397.29B
Operating Income	169.56B
Pretax Income	76.70B
Net Income	58.40B
EBITDA	306.89B
EBIT	169.56B
Earnings Per Share (EPS)	14.24

Balance Sheet

The company has 137.19 billion in cash and 682.86 billion in debt, giving a net cash position of -545.68 billion or -133.08 per share.

Cash & Cash Equivalents	137.19B
Total Debt	682.86B
Net Cash	-545.68B
Net Cash Per Share	-133.08
Equity (Book Value)	2.45T
Book Value Per Share	598.27
Working Capital	751.49B

Cash Flow

In the last 12 months, operating cash flow was 671.66 billion and capital expenditures -41.68 billion, giving a free cash flow of 629.97 billion.

Operating Cash Flow	671.66B
Capital Expenditures	-41.68B
Free Cash Flow	629.97B
FCF Per Share	153.64

Margins

Gross margin is 14.41%, with operating and profit margins of 6.15% and 2.12%.

Gross Margin	14.41%
Operating Margin	6.15%
Pretax Margin	2.78%
Profit Margin	2.12%
EBITDA Margin	11.13%
EBIT Margin	6.15%
FCF Margin	22.84%

Dividends & Yields

PT Suparma Tbk does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	4
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	5.93%
FCF Yield	64.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 10, 2025. It was a forward split with a ratio of 1.3.

Last Split Date	Nov 10, 2025
Split Type	Forward
Split Ratio	1.3

Scores

PT Suparma Tbk has an Altman Z-Score of 2.15 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.15
Piotroski F-Score	6